Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLunglife Ai Regulatory News (LLAI)

  • There is currently no data for LLAI

PLA Code application submitted

12 Oct 2021 07:00

RNS Number : 7230O
LungLife AI, INC
12 October 2021
Β 

Β 

LungLife AI, Inc.(the "Company" or "LungLife")

Β 

PLA Code application submitted in first step in reimbursement process

Β 

LungLife AI (AIM: LLAI), a developer of clinical diagnostic solutions for lung cancer enhanced by artificial intelligence, announces it has submitted its application for a Proprietary Laboratory Analysis (PLA) code to the American Medical Association.

Β 

Reimbursement in the US is comprised of three components: code, price, and coverage. The code is the mechanism by which clinical laboratories can more specifically identify their tests when billing Medicare and commercial insurers. If LungLife's application for a PLA code is granted, the code will be priced for Medicare by the Centers for Medicare & Medicaid Services (CMS) in 2022. PLA code applications can be made at four times in the year.

Β 

For further information please contact:

Β 

LungLife AI, Inc.

www.lunglifeai.com

Paul Pagano, CEOΒ 

Via Walbrook PR

David Anderson, CFO

Β 

Investec Bank plc (Nominated Adviser & Broker)

Tel: +44 (0)20 7597 5970

Daniel Adams / Virginia Bull / Cameron MacRitchie

Β 

Β 

Walbrook PRΒ Limited

Β Tel: +44 (0)20 7933 8780 orΒ LungLifeAI@walbrookpr.com

Paul McManus / Alice Woodings

Mob: 07980 541 893 / 07407 804 654

Β 

Β 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word β€œReach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
NRABCBDGBDBDGBB
12
Date   Source Headline
2nd May 20237:00 amRNSConfirmation of AGM
6th Apr 20233:50 pmRNSPublication of Annual Report & Notice of AGM
14th Mar 20237:00 amRNSAppointment of Joint Broker
13th Mar 20237:00 amRNSStatement re. Silicon Valley Bank
7th Mar 20237:00 amRNSHealth economics publication
27th Feb 20237:00 amRNSData on cost-effectiveness of LungLB®
20th Feb 20237:00 amRNSPreliminary results for year ended 31 Dec 2022
8th Feb 20237:00 amRNSNotice of Results
7th Dec 20222:37 pmRNSHolding(s) in Company
30th Nov 20227:00 amRNSFinal Pricing Determination
30th Nov 20227:00 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSBlock Listing Six Monthly Return
3rd Nov 20227:00 amRNSDirector share purchases
17th Oct 20227:00 amRNSParticipation in National Cancer Institute’s EDRN
26th Sep 20227:00 amRNSHalf-year Report
9th Sep 20227:00 amRNSNotice of Results
2nd Sep 20227:00 amRNSNew York State approval for commercial testing
16th May 20227:00 amRNSBlock Listing Six Monthly Return
11th May 20223:17 pmRNSResult of AGM
8th Apr 20227:00 amRNSPublication of AR and Accounts & Notice of AGM
28th Mar 20227:00 amRNSPreliminary Results
17th Mar 20227:00 amRNSVA sites in validation study; SAB appointment
2nd Feb 20227:00 amRNSFirst patient enrolment for LungLB® study
4th Jan 20227:00 amRNSCPT® Code granted by American Medical Association
19th Nov 20217:00 amRNSLungLife AI Laboratory achieves CAP accreditation
10th Nov 20217:00 amRNSBlock Listing Application
12th Oct 20217:00 amRNSPLA Code application submitted
9th Sep 20217:00 amRNSHalf-year Report
3rd Sep 20217:00 amRNSNotice of Results
28th Jul 20213:08 pmRNSHolding(s) in Company
12th Jul 20219:15 amRNSHolding(s) in Company
9th Jul 20213:35 pmRNSHolding(s) in Company
8th Jul 20213:45 pmRNSHolding(s) in Company
8th Jul 20218:00 amRNSDirector/PDMR Shareholding
8th Jul 20217:00 amRNSAdmission to AIM & First Day of Dealings
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.